[go: up one dir, main page]

DE60120621D1 - Lawsonia intracellularis Impfstoff - Google Patents

Lawsonia intracellularis Impfstoff

Info

Publication number
DE60120621D1
DE60120621D1 DE60120621T DE60120621T DE60120621D1 DE 60120621 D1 DE60120621 D1 DE 60120621D1 DE 60120621 T DE60120621 T DE 60120621T DE 60120621 T DE60120621 T DE 60120621T DE 60120621 D1 DE60120621 D1 DE 60120621D1
Authority
DE
Germany
Prior art keywords
relates
lawsonia intracellularis
nucleic acid
detection
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60120621T
Other languages
English (en)
Other versions
DE60120621T2 (de
Inventor
Antonius A C Jacobs
Paul Vermeij
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International BV filed Critical Intervet International BV
Application granted granted Critical
Publication of DE60120621D1 publication Critical patent/DE60120621D1/de
Publication of DE60120621T2 publication Critical patent/DE60120621T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60120621T 2000-12-20 2001-12-14 Lawsonia intracellularis Impfstoff Expired - Lifetime DE60120621T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00204660 2000-12-20
EP00204660 2000-12-20

Publications (2)

Publication Number Publication Date
DE60120621D1 true DE60120621D1 (de) 2006-07-27
DE60120621T2 DE60120621T2 (de) 2006-12-14

Family

ID=8172486

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60120621T Expired - Lifetime DE60120621T2 (de) 2000-12-20 2001-12-14 Lawsonia intracellularis Impfstoff
DE60144201T Expired - Lifetime DE60144201D1 (de) 2000-12-20 2001-12-14 Lawsonia intracellularis Impfstoff

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60144201T Expired - Lifetime DE60144201D1 (de) 2000-12-20 2001-12-14 Lawsonia intracellularis Impfstoff

Country Status (12)

Country Link
US (2) US6921536B2 (de)
EP (2) EP1586646B1 (de)
JP (1) JP4237960B2 (de)
AT (2) ATE330013T1 (de)
AU (1) AU783210B2 (de)
CA (1) CA2365494A1 (de)
DE (2) DE60120621T2 (de)
DK (2) DK1586646T3 (de)
ES (2) ES2360225T3 (de)
HU (1) HUP0105379A3 (de)
PL (1) PL205964B1 (de)
PT (1) PT1219711E (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1586646T3 (da) * 2000-12-20 2011-06-27 Intervet Int Bv Lawsonia intracellularis-vaccine
CA2499885C (en) 2002-05-29 2010-04-20 Yamasa Corporation Novel polyphosphate:amp phosphotransferase
BRPI0413857A (pt) * 2003-09-12 2006-10-24 Akzo Nobel Nv seqüência de ácido nucleico, fragmento de dna, molécula de dna recombinante, veìculo recombinante vivo, célula hispedeira, proteìna de lawsonia intracellularis, uso de uma proteìna de lawsonia intracellularis, vacina para combater infecções por lawsonia intracellularis, método para a preparação de uma vacina, e, teste diagnóstico
MXPA06008217A (es) * 2004-01-22 2007-05-23 Intervet Int Bv Vacunas con subunidad de lawsonia intracellularis.
EP1609870A1 (de) * 2004-06-24 2005-12-28 Boehringer Ingelheim Vetmedica Gmbh Methode, um Lawsonia intracellularis zu diagnostizieren
MY146476A (en) 2004-06-24 2012-08-15 Boehringer Ingelheim Vetmed Method of diagnosing lawsonia intracellularis
WO2006056853A1 (en) * 2004-11-24 2006-06-01 Pharmacia & Upjohn Company Llc Methods for cultivating lawsonia intracellularis
US8834891B2 (en) * 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
JP2008538502A (ja) * 2005-04-18 2008-10-30 ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド サブユニットワクチン中の構成成分として有用なローソニアタンパク並びにその製造方法及び使用方法
US8398994B2 (en) 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US8470336B2 (en) 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
US20080241190A1 (en) * 2006-11-13 2008-10-02 Boehringer Ingelheim Vetmedica, Inc. Vaccination of horses against lawsonia intracellularis
WO2008073464A2 (en) 2006-12-11 2008-06-19 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
EP2200643B1 (de) 2007-09-17 2013-09-04 Boehringer Ingelheim Vetmedica, Inc. Ein lawsonia intracellularis lebendimpfstoff verabreicht in kombination mit einem antibiotikum zur behandlung von lawsonia intracellularis infektionen in schweine
TWI551295B (zh) 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
TWI449533B (zh) * 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
WO2010010055A1 (en) * 2008-07-22 2010-01-28 Intervet International B.V. Lawsonia intracellularis bacterium of a novel serotype, vaccine based on that bacterium, antibodies suitable for diagnosing the novel lawsonia intracellularis serotype and hybridomas for producing the said antibodies
KR101837768B1 (ko) 2011-05-25 2018-03-12 건국대학교 산학협력단 돼지 증식성 회장염을 진단하기 위한 단백질 및 그 응용
US20140017268A1 (en) * 2012-06-05 2014-01-16 Regents Of The University Of Minnesota Composition and Methods for Detecting or Preventing Lawsonia intracellularis Infections
JP2018504423A (ja) 2015-02-04 2018-02-15 インターベット インターナショナル ベー． フェー． 豚における無症候性ローソニア感染症に対する使用のためのワクチン
JP2018504424A (ja) 2015-02-04 2018-02-15 インターベット インターナショナル ベー． フェー． 豚における無症候性ローソニア感染症に対する使用のためのワクチン
BR112018007525A2 (pt) * 2015-10-16 2018-10-30 Kansas State University Research Foundation composições imunogênicas de circovírus suíno tipo 3 e métodos de produzir e usar as mesmas
CL2017002196A1 (es) 2017-08-30 2017-11-17 Univ De Concepción Vacuna recombinante contra enteropatía proliferativa en animales.
CN113528683A (zh) * 2021-07-09 2021-10-22 南京农业大学 一种用于检测胞内劳森菌的绝对荧光定量pcr引物对、试剂盒及检测方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310993A (en) 1980-01-07 1982-01-19 Louvers & Dampers, Inc. Louver assembly
ES2056565T3 (es) 1990-07-30 1994-10-01 Akzo Nobel Nv Virus recombinante de la enfermedad de marek.
WO1993004163A1 (en) 1991-08-23 1993-03-04 Massachusetts Institute Of Technology Strain of chlamydia
US5610059A (en) * 1992-11-09 1997-03-11 University Of Arizona Etiological agent for porcine enteritis
FR2714074B1 (fr) 1993-12-20 1996-03-01 Pasteur Institut Promoteurs des gènes GRA1, GRA2, GRA5 et GRA6 de toxoplasma gondii et vecteurs d'expression comprenant lesdits promoteurs.
US5885823A (en) 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
US5714375A (en) * 1995-06-05 1998-02-03 Nobl Laboratories, Inc. Ileal symbiont intracellularis propagation in suspended host cells
ATE329031T1 (de) * 1995-11-30 2006-06-15 Agriculture Victoria Serv Pty Therapeutische zusammensetzungen zur behandlung von lawsonia intracellularis infektionen
BR0011292A (pt) 1999-05-13 2002-02-26 Pfizer Prod Inc Gene derivado de lawsonia e proteìnas, peptìdeos e polipeptìdeos sodc relacionados e seus usos
WO2000069906A1 (en) 1999-05-13 2000-11-23 Pfizer Products Inc Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses
BR0011290A (pt) * 1999-05-13 2002-05-21 Agriculture Victoria Serv Pty Gene derivado de lawsonia e polipeptìdeos, peptìdeos e proteìnas de omph relacionados e seus usos
EP1181315A4 (de) 1999-05-13 2002-08-14 Pfizer Prod Inc VON LAWSONIA ABSTAMMENDE GENE UND VERWANDTE F1gE POLYPEPTIDE, PEPTIDE UND PROTEINE UND IHRE VERWENDUNGEN
EP1094070A3 (de) 1999-10-22 2002-01-09 Pfizer Products Inc. Lawsonia intracellularis Proteine sowie Methoden und Materialien die diese verwenden
US6605696B1 (en) * 1999-10-22 2003-08-12 Pfizer, Inc. Lawsonia intracellularis proteins, and related methods and materials
DK1586646T3 (da) * 2000-12-20 2011-06-27 Intervet Int Bv Lawsonia intracellularis-vaccine

Also Published As

Publication number Publication date
HUP0105379A3 (en) 2004-07-28
CA2365494A1 (en) 2002-06-20
US7491401B2 (en) 2009-02-17
JP2003000276A (ja) 2003-01-07
HUP0105379A2 (hu) 2003-01-28
DE60120621T2 (de) 2006-12-14
PL205964B1 (pl) 2010-06-30
US6921536B2 (en) 2005-07-26
DK1586646T3 (da) 2011-06-27
DK1219711T3 (da) 2006-09-25
PT1219711E (pt) 2006-10-31
AU783210B2 (en) 2005-10-06
EP1219711A3 (de) 2002-11-06
ATE501258T1 (de) 2011-03-15
ES2360225T3 (es) 2011-06-02
PL351277A1 (en) 2002-07-01
HU0105379D0 (en) 2002-02-28
US20050069559A1 (en) 2005-03-31
JP4237960B2 (ja) 2009-03-11
ATE330013T1 (de) 2006-07-15
US20050250150A1 (en) 2005-11-10
EP1586646A2 (de) 2005-10-19
EP1219711A2 (de) 2002-07-03
AU9737101A (en) 2002-06-27
EP1219711B1 (de) 2006-06-14
DE60144201D1 (de) 2011-04-21
EP1586646B1 (de) 2011-03-09
EP1586646A3 (de) 2007-08-01
ES2266090T3 (es) 2007-03-01

Similar Documents

Publication Publication Date Title
DE60120621D1 (de) Lawsonia intracellularis Impfstoff
ATE470673T1 (de) Impfstoffe mit lawsoniaintrazellularis- untereinheit
WO2002080851A3 (en) Chimeric vaccines
DE60139690D1 (de) Immunisierung gegen chlamydia pneumoniae
ATE406912T1 (de) Immunisierung gegen chlamydia tracheomatis
DE60131858D1 (de) Borrelia burgdorferi rekombinante genkonstrukte
ATE450545T1 (de) Impfstoff mit lawsonia intracellularis- untereinheit
WO2004098526A3 (en) Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
WO2003095480A3 (en) Brachyspira hyodysenteriae vaccine
WO2004020609A3 (en) Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection
WO2004007726A3 (en) Brachyspira hyodysenteriae vaccine
ATE417106T1 (de) Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon
ZA200602107B (en) Piroplasmid vaccine
NO20081541L (no) Ny sjo-lus vaksine
ATE366583T1 (de) Identifizierung von spezifischen differenziell exprimierten antigenen aus mycobacterium und medizinische verwendung der mycobakteriumproteine rv0068 und rv3407
PT1176192E (pt) Vacina de helicobacter felis
WO2004024769A3 (en) Ostertagia vaccine
TH62170A (th) วัคซีนเชื้อก่อโรค Lawsonia intracellularis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition